A Columbia University research performed in collaboration with the Observational Health Data Sciences and Informatics (OHDSI) program indicates that there is no generalization in the treatment of diabetes worldwide. The results were published online in Proceedings of the National Academy of Sciences as per Medical News Today (MNT ) Newsletter June 7,2016. OHDSI pronunced as Odyssey by these researchers is definitely a long journey of experience involving 250 million patient records involving four countries. Although the patients with type2 diabetes worldwide are initially treated with metformin, there is wide variation in the second-line treatment. OHDSI program is a collaborative program allows researchers to combine and analyze patient data from widely different sources in the US and abroad. Columbia University serves as OHDSI’s coordinating center. Currently, the research collaborative involves more than 600 million patient records from 14 countries.
Full information on this research can be had through this link